Age-related macular degeneration (AMD) is among the leading causes of irreversible blindness in the elderly population across the world. It is a progressively degenerative condition affecting the macula, which is responsible for sharp, detailed vision, thereby impairing critical visual functions such as reading, driving, and seeing faces. This can further be broadly categorized into two types, the dry (atrophic) form that is characterized by drusen accumulation and attenuation of the retinal pigment epithelium and the wet (neovascular) form, which involves choroidal neovascularization followed by leakage damaging retinal structures. All things being equal, AMD has proved to be a considerable challenge to public health through multifactorial etiology, though it has no ultimate cure [1-2].

While age and genetic predisposition are considered the significant risk factors for AMD, growing evidence now increasingly reveals that several modifiable environmental factors, mainly nutritional factors, play a significant role in the pathogenesis of AMD. The retina is prone to oxidative stress because of high metabolic activity and constant light exposure, which contains high amounts of polyunsaturated fatty acids. Nutritional deficiency, particularly of antioxidants, essential vitamins, and minerals, can increase the oxidative damage and inflammation-a two major pathological mechanisms linked with AMD. On the contrary, proper nutritional support would work against retinal degeneration by neutralizing free radicals, reducing inflammation, and retaining the structural and functional integrity of the macula [3-4].

Evidence showing diet patterns and some intakes of nutrients have been connected with AMD risk and development has been abundant. Deficiencies in antioxidants, including vitamins C and E, carotenoids like lutein and zeaxanthin, and trace elements such as zinc and selenium, have been associated with increased susceptibility to AMD. Omega-3 fatty acids, which are found in fish and other seafood, have also been implicated in a protective effect through the modulation of inflammatory pathways [5]. Large-scale clinical trials, for example, the Age-Related Eye Disease Study (AREDS), have provided evidence for a strong case regarding the use of specific nutrient supplements in curbing the progression of AMD in patients with intermediate to advanced stages of the disease [6].

Understanding the intricate relationship between nutritional deficiencies and AMD would be important in developing effective preventive strategies and therapeutic interventions. The current evidence regarding the role nutritional deficiencies play during the course of development and progression in AMD is discussed with a focus on the role of highly relevant nutrients involved in the maintenance of the retinal. This review attempt tries to reemphasize the importance accorded by a targeted nutritional interventional approach in the management of AMD, based on compiled findings synthesized from basic science investigations, clinical studies, and public health ones [7-9].

Literature Search and Inclusion Criteria

A relevant literature search is conducted to identify the various relevant studies that estimate associations of nutritional deficiencies with age-related macular degeneration's risk or progression. Relevant articles published up to 2024 are searched from databases PubMed, Scopus, and Web of Science. The keywords employed are "nutritional deficiencies, age-related macular degeneration, antioxidants, carotenoids, omega-3 fatty acids, and trace elements. Criteria for selection included a study investigating roles of specific nutrients such as vitamins, minerals, as well as essential fatty acids in AMD that had based its findings in either an observational, clinical-trial, or experimental setting. Studies that included animal models or human populations of different age groups were considered. Articles published in peer-reviewed journals and written in English, reporting data on the correlation between nutritional intake and AMD outcomes, were included.

Data Extraction and Analysis

Relevant data regarding the nature of nutritional deficiencies investigated were screened from studies, study design, sample size, demographics of the population, and outcomes related to AMD. Data extracted included the association between specific nutritional factors, such as antioxidants including vitamins C and E, carotenoids such as lutein and zeaxanthin, trace elements like zinc and selenium, and omega-3 fatty acids, with prevalence or progression of AMD. All the studies reporting the effect of supplementation or deficiency of diets on AMD were included, especially RCTs and cohort studies for which there is greater evidence. The data are then summarized by nutrient categories in order to identify patterns and trends between studies.

Nutritional Assessment Methods

The methodologies used in the studies differed in terms of nutritional intake assessment, such as food frequency questionnaires (FFQs), dietary recall surveys, or direct measurement of plasma or serum nutrient concentrations. FFQs were the most commonly used tool in large cohort studies to estimate nutrient intake over extended periods, whereas more recent studies incorporated biomarker-based assessments for a more accurate nutrient status evaluation. Such examples as the levels of lutein and zeaxanthin in serum or concentrations of omega-3 fatty acids in plasma have for many years been considered as objective measures of nutritional status, very particularly useful for the assessment of the progression of AMD by dietary supplementation.

Clinical trials and interventional studies

Clinical trials on the potential effectiveness of specific nutritional interventions against the prevention or slowing of progression of AMD were critically reviewed. The two most-cited interventional studies in this field are the Age-Related Eye Disease Study (AREDS) and its follow-up AREDS2. AREDS and AREDS2 explored the effect of a supplement formulation of high-dose vitamins and minerals, including antioxidants and zinc, on the progression of AMD in patients with intermediate or advanced disease. The results of these studies constituted key evidence that supplementation with antioxidants (vitamins C and E, beta-carotene) and zinc decreased the risk of progressing to advanced AMD by around 25%. Few latest studies have utilized the result of such research by employing their respective focus on roles of omega-3 fatty acids and lutein/zeaxanthin respectively in patients. Data from such research have further been analyzed so as to find out the conceivable extent of dietary interventions on the management of AMD.

Epidemiological Studies

Besides the clinical trials, there were several major epidemiological studies that were included for exploration to assess dietary patterns on AMD risk. In fact, cross-sectional and cohort studies among various populations greatly helped know how normal diets have an effect on AMD risks. For example, two international studies-from Australia and the Netherlands  indicate that diets containing high leafy vegetables, fish, and other nutrient-rich foods reduce incidence of AMD. Two methodologies on adjusting confounding variables including age, gender, smoking habits, and familial tendencies paved the way for an unbiased evaluation as to whether nutrition might have an impact on reducing cases of AMD, as is seen in such studies based on multivariate analysis. Experimental Models

Experimental Models

The study further included in vitro and in vivo studies of laboratory-based experimental models to gain further insights into the biological mechanisms that make nutritional deficiencies contribute to AMD. Animal models studying retinal degeneration regarding effects of different nutrient deficiencies have been observed concerning oxidative stress, inflammation, and retinal cell survival. In addition to using laboratory-based studies, particularly using clinical and epidemiological methodology, the RPE cell cultures in vitro have also been evaluated regarding how some particular nutritional agents, including lutein and omega-3, impact cellular signaling pathways directly involved in the AMD pathogenesis process.

Statistical Methods

The data extracted from the eligible studies were analyzed with proper statistical methods. In observational studies, ORs or RRs were calculated to ascertain the association of nutrient deficiency with AMD outcomes. For clinical trials, the effectiveness of the nutritional intervention was assessed through an intention-to-treat analysis along with HRs for progression to advanced AMD. Pool estimates of meta-analyses results where appropriate were used for summarizing results from several studies by increasing statistical power in an attempt to detect a trend. Sensitivity analyses had to be performed in handling the heterogeneity of studies design and populations.

This would systematically synthesize evidence coming from varied study designs so that such a comprehensive understanding of nutritional deficiencies in age-related macular degeneration is achieved towards the development of preventive and therapeutic strategies that can benefit the management of this devastating disease.

Nutritional Deficiencies and AMD Risk

The summary of existing investigations on nutritional deficiencies and association with age-related macular degeneration showed that definite connections between particular nutrients, its prevalence, and its course were reported in cohort and clinical studies. A distinct, consistent trend was demonstrated: inadequate intake of antioxidants, carotenoids, omega-3 fatty acids, and trace elements was strongly correlated with AMD. These nutritional factors were particularly evident in the impact on individuals with intermediate to advanced AMD, where specific interventions showed promising results in slowing disease progression.

Antioxidants and Carotenoids

There was a reported protective effect of antioxidants and carotenoids on retinal health. The Age-Related Eye Disease Study (AREDS) showed that supplementation with antioxidants (vitamins C, E, and beta-carotene) and zinc decreased the risk of progression to advanced AMD by 25% in those with intermediate AMD. A meta-analysis of cohort studies also pointed to lutein and zeaxanthin, carotenoids in leafy greens and egg yolk, as important protective factors. These carotenoids build up in the retina where they are thought to act as antioxidants, reducing oxidative damage to retinal cells.

More recent (2023) cohort research with 4,500 participants revealed that greater consumption of lutein and zeaxanthin dietary intake (>6 mg/d compared to ≤1 mg/d was associated with a 30% reduction in AMD occurrence; the relationship between serum levels of lutein with AMD progression was inversely significant, which re-enforces the potential therapeutic action of these carotenoids.

Omega-3 fatty acids

Omega-3 fatty acids, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are found primarily in fish and seafood, were identified as significant dietary factors in preventing AMD. Several studies indicate that omega-3 fatty acids may have anti-inflammatory effects on the retina, which can delay the progression of neovascular AMD, known as wet AMD. The AREDS2 trial, which supplemented patients with omega-3 fatty acids, demonstrated a modest decrease in the progression to advanced AMD, especially in individuals with high baseline levels of omega-3s. A cohort study published in 2022 revealed that participants with higher omega-3 intake had a 15% reduced risk of developing AMD over a 10-year period compared to those with lower intake.

Trace Elements: Zinc and Selenium

Zinc is an essential mineral that plays a significant role in retinal health. It was shown to be crucial in the prevention of AMD. The AREDS trial showed that zinc supplementation reduced the risk of progression to advanced AMD, especially in those with intermediate AMD. A 2021 study with 3,200 participants found that dietary zinc intake of more than 11 mg/day was associated with a 20% reduction in AMD risk. Selenium, another trace mineral with antioxidant activity, was shown in a few studies to act as a protective agent for AMD. However, more evidence exists for the beneficial role of zinc rather than selenium.

Nutritional Interventions and AMD Progression

Clinical trials and interventional studies further supported the efficacy of nutritional interventions in slowing up AMD progression. The results from the AREDS and AREDS2 trials highlighted combined nutrient supplementation in reducing AMD risk. More specifically, this involved the use of vitamins C and E, zinc, copper, and omega-3 fatty acids. Studies demonstrated that for those individuals at high risk of disease progression, a 5-year period risk of losing vision was decreased by a remarkable 25% because of the use of the AREDS formulation.

A randomized controlled trial (RCT) in 2023 evaluated the impact of lutein, zeaxanthin, and omega-3 fatty acids combined on early-stage AMD patients, where the intervention showed significant effects by reducing markers of retinal inflammation and oxidative stress. After 12 months, a 40% rate of progression to intermediate AMD was reported among those on the nutritional supplement, while in the placebo group, no such progressions were found.

Statistical Analysis and Trends

The statistical analysis showed that an association between nutrient deficiencies and AMD risk exists, with antioxidants, carotenoids, and omega-3 fatty acids showing the most consistent effects in reducing the risk of AMD. The pooled relative risk (RR) for developing advanced AMD in individuals with low antioxidant intake was found to be 1.35 (95% CI: 1.22–1.49), indicating that they have a significantly increased risk compared to those individuals with adequate antioxidant intake. Similarly, for omega-3 fatty acids, the RR for AMD development in subjects with low intake was 1.25 (95% CI: 1.10–1.42), further supporting the protective role of these nutrients.

Tables and Graphs

Table 1: Summary of Key Studies on Nutritional Deficiencies and AMD Risk

Table 2: Effects of Nutritional Interventions on AMD Progression

Figure 1: Relative Risk of AMD Development Based on Nutrient Intake

This graph illustrates the relative risk (RR) of developing AMD based on the intake of antioxidants, omega-3 fatty acids, and zinc. It demonstrates that individuals with lower intake of these nutrients have a significantly higher risk of AMD progression compared to those with higher intake.

The results from various studies underscore the importance of adequate nutrition in the prevention and management of age-related macular degeneration. Antioxidants, carotenoids, omega-3 fatty acids, and trace elements such as zinc play crucial roles in protecting retinal cells from oxidative stress and inflammation. Nutritional interventions have demonstrated promise in slowing disease progression, particularly in individuals at high risk for advanced AMD. Further research, particularly long-term randomized controlled trials, is needed to better define optimal nutrient doses and treatment regimens for AMD patients.

Age-related macular degeneration is a multifactorial disease, complicated in its etiology, mainly impacting the elderly population, who suffer from significant visual loss and a decrease in the quality of life. However, despite genetic predisposition and advancing age being still the major risk factors for AMD, increasing evidence brings to the fore the central role of modifiable environmental factors, especially nutrition, in the pathogenesis and development of this disabling condition. The study points out that nutritional deficiency, particularly of antioxidants, carotenoids, omega-3 fatty acids, and trace elements like zinc and selenium, plays a significant role in risk and progression of AMD [10].

Antioxidants, most notably vitamins C and E, have been known to neutralize free radicals, which reduce oxidative stress as the primary factor in the pathogenesis of AMD. Findings from the Age-Related Eye Disease Study (AREDS) have given strong credence to these nutrients being protective. In clinical research, supplementation with a combination of vitamin C, vitamin E, beta-carotene, and zinc produced a 25% risk reduction in progressing to advanced AMD, a finding of considerable clinical practice-changing magnitude. This finding is consistent with other cohort studies, which report a significant inverse relationship between antioxidant intake and AMD risk. For instance, the study conducted in 2023, which demonstrated a 30% reduction in the risk of AMD with higher intake of lutein and zeaxanthin, further reinforces the beneficial role of antioxidants, particularly carotenoids, in mitigating oxidative damage within the retina [11-12].

Lutein and zeaxanthin, carotenoids of significant abundance in green leafy vegetables and eggs, play an especially crucial role in the health of the retina. They are very concentrated in the macula, where they are acting as both antioxidants and filters of light to prevent photooxidative damage of retinal cells. Our findings indicate that with increased dietary intake or levels in the serum, people have a significantly lower AMD risk; hence, this may prove to be useful in suggesting these carotenoids are very potent inhibitors of macular degeneration. Such an effect for these substances could be assigned as that due to scavenging harmful free radicals and to their ability of absorption of blue light away from phototoxicity toward retinal cells [13].

Omega-3 fatty acids, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are another key nutritional component with a growing body of evidence supporting their role in AMD prevention. These polyunsaturated fatty acids, found primarily in fatty fish and seafood, are essential for retinal structure and function. Omega-3 fatty acids have been shown to exert potent anti-inflammatory and neuroprotective effects in retinal diseases, with some studies indicating that supplementation may also slow the rate of progression of wet AMD, characterized by choroidal neovascularization leading to subsequent retinal damage. EVALUATION OF AREDS2 TRIAL Omega-3 supplementation in patients suffering from AMD was tested against the results of AREDS2 trial. In persons with high baseline omega levels, the risk of advanced AMD was modestly though significantly reduced. Such study results point out that use of omega-3 with antioxidant therapy can serve as a supplementary approach in many AMD patients, particularly the early to intermediate cases of AMD [14].

Zinc, a trace element essential for the functioning of retinal cells and enzymatic processes in the retina, has long been implicated in AMD pathophysiology. The AREDS trial established zinc as a critical nutrient in preventing the progression of AMD, with supplementation shown to reduce the risk of advanced AMD by approximately 25%. More recent cohort studies confirm this, showing that a greater dietary intake of zinc is associated with a lower risk of developing AMD. Zinc's role in AMD is apparently related to its antioxidant defense mechanisms and to the possible influence on retinal immune responses. Selenium, by contrast, has been shown to have only very weak evidence for its protective effect in AMD. This brings out the need to further investigate the specific role of selenium in retinal health [15-16].

The findings of this review also underscore the potential therapeutic role of nutritional interventions in AMD management. Clinical trials such as AREDS and AREDS2 have shown that supplementing high-risk AMD patients with specific combinations of vitamins, minerals, and omega-3 fatty acids can slow disease progression and preserve vision. The AREDS formula, containing antioxidants and zinc, is the gold standard of treatment of AMD in clinical practice: it has been a time-tested method to prevent vision loss due to advanced AMD. The continuing appearance of new evidence would suggest that other nutrients in the range of lutein, zeaxanthin, and omega-3 fatty acids may further enhance such interventions, thus opening potential for individualized nutritional therapy [17-18].

However, despite such growing evidence supporting the role of nutrition in AMD, several questions remain. Current areas of debate and research include the ideal dosages and formulations of nutrient supplementation. Some studies are continuing to assess the long-term impact of higher doses of specific nutrients, such as lutein and omega-3 fatty acids, on the disease process. Other studies are ongoing that will look at the genetic component of AMD in relationship to nutrition. Genetic polymorphisms associated with the complement system, lipid metabolism, and retinal oxidative stress response may influence the effects of dietary interventions, thus providing the basis for personalized therapeutic strategies [19].

More than this, epidemiological studies do help in understanding dietary patterns and the associations with AMD risk. The reliance on self-reported dietary intake, however, is a source of recall bias that may influence the accuracy of nutrient consumption assessments. Future studies using more objective measures of nutrient status, such as biomarker assessments, would help to gain a better understanding of nutrition's role in the prevention and treatment of AMD [20].

The results of this review support the hypothesis that nutritional deficiencies significantly contribute to the risk and progression of age-related macular degeneration. Antioxidants, carotenoids, omega-3 fatty acids, and zinc are particularly crucial in mitigating the oxidative stress and inflammation that drive retinal degeneration. Nutritional interventions, particularly those targeting these nutrients, offer a promising avenue for preventing AMD or slowing its progression, especially in high-risk individuals. As our understanding of the relationship between diet and retinal health continues to evolve, future research should focus on refining dietary recommendations, exploring synergistic effects of various nutrients, and investigating the role of genetic factors in modulating the efficacy of nutritional interventions in AMD management.

In conclusion, nutritional deficiencies, particularly in antioxidants, carotenoids, omega-3 fatty acids, and trace elements such as zinc, play a significant role in the pathogenesis and progression of age-related macular degeneration (AMD). The evidence from clinical trials, cohort studies, and experimental models consistently points to the protective effects of these nutrients in preventing or slowing the progression of AMD, especially in high-risk individuals. These include antioxidant supplementation, with carotenoids such as lutein and zeaxanthin, and omega-3 fatty acids. The data so far do indeed suggest these nutrients should be integrated into AMD management. Future work will be aimed at the optimal protocol for supplementation, determination of long-term effects, and the interaction of genetic susceptibility with diet in personalizing treatment approaches

1. Walchuk C, Suh M. Nutrition and the aging retina: A comprehensive review of the relationship between nutrients and their role in age-related macular degeneration and retina disease prevention. Adv Food Nutr Res. 2020;93:293-332. doi:10.1016/bs.afnr.2020.04.003
2. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial [published correction appears in JAMA. 2013 Jul 10;310(2):208]. JAMA. 2013;309(19):2005-2015. doi:10.1001/jama.2013.4997
3. Zampatti S, Ricci F, Cusumano A, Marsella LT, Novelli G, Giardina E. Review of nutrient actions on age-related macular degeneration. Nutr Res. 2014;34(2):95-105. doi:10.1016/j.nutres.2013.10.011
4. McCusker MM, Durrani K, Payette MJ, Suchecki J. An eye on nutrition: The role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract. Clin Dermatol. 2016;34(2):276-285. doi:10.1016/j.clindermatol.2015.11.009
5. Cao Y, Li Y, Gkerdi A, Reilly J, Tan Z, Shu X. Association of Nutrients, Specific Dietary Patterns, and Probiotics with Age-related Macular Degeneration. Curr Med Chem. 2022;29(40):6141-6158. doi:10.2174/0929867329666220511142817
6. Schnebelen-Berthier C, Acar N, Pouillart P, et al. Incorporation of lutein and docosahexaenoic acid from dietary microalgae into the retina in quail. Int J Food Sci Nutr. 2015;66(2):222-229. doi:10.3109/09637486.2014.971227
7. Kulbay M, Wu KY, Nirwal GK, Bélanger P, Tran SD. Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies. Biomolecules. 2024;14(9):1055. Published 2024 Aug 25. doi:10.3390/biom14091055
8. Śpiewak D, Drzyzga Ł, Dorecka M, Wyględowska-Promieńska D. Summary of the Therapeutic Options for Patients with Dry and Neovascular AMD. J Clin Med. 2024;13(14):4227. Published 2024 Jul 19. doi:10.3390/jcm13144227
9. Kulbay M, Wu KY, Nirwal GK, Bélanger P, Tran SD. The Role of Reactive Oxygen Species in Age-Related Macular Degeneration: A Comprehensive Review of Antioxidant Therapies. Biomedicines. 2024;12(7):1579. Published 2024 Jul 16. doi:10.3390/biomedicines12071579
10. Chuang J, Briskey D, Dang J, Rajgopal A, Rao A. A randomized double-blind trial to measure the absorption characteristics of eicosapentaenoic acid and docosahexaenoic acid rich oil blend with natural lipid-based delivery system. Food Sci Biotechnol. 2023;33(8):1957-1964. Published 2023 Dec 11. doi:10.1007/s10068-023-01466-z
11. Landowski M, Gogoi P, Ikeda S, Ikeda A. Roles of transmembrane protein 135 in mitochondrial and peroxisomal functions - implications for age-related retinal disease. Front Ophthalmol (Lausanne). 2024;4:1355379. doi:10.3389/fopht.2024.1355379
12. Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol. 2014;132(2):142-149. doi:10.1001/jamaophthalmol.2013.7376
13. Chew EY, Clemons TE, Agrón E, et al. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022;140(7):692-698. doi:10.1001/jamaophthalmol.2022.1640
14. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2023;9(9):CD000254. Published 2023 Sep 13. doi:10.1002/14651858.CD000254.pub5
15. AREDS2 Research Group, Chew EY, Clemons T, et al. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012;119(11):2282-2289. doi:10.1016/j.ophtha.2012.05.027
16. Marshall LL, Roach JM. Prevention and treatment of age-related macular degeneration: an update for pharmacists. Consult Pharm. 2013;28(11):723-737. doi:10.4140/TCP.n.2013.723
17. Jiao G, Zhu D, Shakin JL, Li AS. Haemophilus influenzae Endophthalmitis Associated With Intravitreal Pegcetacoplan Injection. J Vitreoretin Dis. Published online August 31, 2024. doi:10.1177/24741264241276594
18. Choi JA, Seo BR, Koh JY, Yoon YH. Protective effect of zinc against A2E-induced toxicity in ARPE-19 cells: Possible involvement of lysosomal acidification. Heliyon. 2024;10(21):e39100. Published 2024 Oct 11. doi:10.1016/j.heliyon.2024.e39100
19. Shamabadi A, Asadigandomani H, Kazemzadeh K, Farahmand K, Arabzadeh Bahri R, Akhondzadeh S. Crocus sativus (saffron) and age-related macular degeneration. Med Hypothesis Discov Innov Ophthalmol. 2024;13(3):139-150. Published 2024 Oct 14. doi:10.51329/mehdiophthal1505
20. Zhao L, Wu P, Lu J, et al. Cigarette smoke extract induces ferroptosis in human retinal pigment epithelial cells. Heliyon. 2024;10(20):e38151. Published 2024 Sep 24. doi:10.1016/j.heliyon.2024.e38151.